Atherectomy Devices Market Research Report, by Product Type (Directional Atherectomy Systems, Orbital Atherectomy Systems, and others), by Application (Cardiovascular, Neurovascular, Peripheral Vascular, and others), by End User–Forecast Till 2030

Atherectomy Devices Market Overview

In addition, the global atherectomy devices market is expected to reach USD 681.43 Million by 2030 at 11.9% CAGR during the forecast period 2022-2030.

Atherectomy devices refer to various minimally invasive instruments used for peripheral vascular intervention procedures. They are designed to re-establish blood flow in the arteries by drilling, grinding, shaping, sanding, and to vaporize plaque, calcifying lesions and excessive cellular material. Some commonly used atherectomy devices include direction, orbital, photo-ablative, rotational, and support. The devices consist of a rotating blade inside a tubular catheter attached to a battery-operated motor that spins the cutter and removes the plaque or calcified lesion. As a result, atherectomy devices find extensive applications in hospitals, surgical centers and ambulatory care centers.

The increasing prevalence of peripheral artery disease, atherosclerosis, diabetes and obesity and the rising geriatric population across the globe represent the key factors driving the market's growth. Furthermore, the growing preference for atherectomy surgical procedures among patients and healthcare providers is creating a positive outlook for the market. These devices reduce the risks of infections, cause minimal pain and trauma during the surgery and facilitate faster recovery of the patient. Additionally, various product innovations, such as the development of drug-coated balloons, are acting as other growth-inducing factors. The drug-coated balloons are used in place of permanent implants with directional atherectomy and anti-restenosis therapy to deliver antiproliferative drugs and treat lesions with severe calcifications.

Segmentation

The atherectomy devices market is segmented on the basis of product type, application, and end user.

The atherectomy devices market, by product type is categorised into directional atherectomy systems, orbital atherectomy systems, photo-ablative (laser) atherectomy systems, rotational atherectomy systems, and others.

The directional atherectomy systems segment is expected to hold the largest share owing to the high treatment rate, whereas the photo-ablative (laser) atherectomy systems is expected to be the fastest growing segment owing to the growing preference by surgeons.

Based on application, the atherectomy devices market is segmented into cardiovascular, neurovascular, peripheral vascular, and others.

On the basis of end user, the market is segmented into hospitals, ambulatory surgery centers, and others.

On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and Latin America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, South Korea, and the rest of Asia-Pacific. The atherectomy devices market in the Middle East and Africa has been segmented into the Middle East and Africa.

Regional Market Summary

It is projected that the Americas dominated the atherectomy devices market owing to the growth of the market in the North American region. This is largely attributed to the factors such as increase in research funding, and growing awareness about the high-end atherectomy devices among medical professionals. Europe is expected to hold the second largest share in the market owing to growing healthcare infrastructure. Additionally, various initiatives by public and private organizations is anticipated to boost the growth of the market. Asia-Pacific was projected to be the fastest growing region for the market. This owes to the technological advancements resulting in the development of cost-effective atherectomy devices leading to high acceptance rate for the devices in the Asia-Pacific region. The Middle East and Africa holds the least share in the atherectomy devices market due to the presence of economically diverse countries, and less initiatives taken by the government.

Market of Atherectomy Devices, by Product type

• Directional Atherectomy Systems


• Orbital Atherectomy Systems


• Photo-Ablative (Laser) Atherectomy Systems


• Rotational Atherectomy Systems


• Others

Market of Atherectomy Devices, by Application

• Cardiovascular


• Neurovascular


• Peripheral Vascular


• Others

Market of Atherectomy Devices, by End User

• Hospitals


• Ambulatory Surgery Centers


• Others

Market of Atherectomy Devices, by Region

• Americas




• North America




• US


• Canada




• Latin America




• Europe




• Western Europe




• Germany


• France


• Italy


• Spain


• UK


• Rest of Western Europe




• Eastern Europe




• Asia-Pacific




• Japan


• China


• India


• Australia


• South Korea


• Rest of Asia-Pacific




• The Middle East & Africa




• Middle East


• Africa

Atherectomy devices market, Key Players

• Abbott


• Avinger


• Braun Melsungen AG


• Biomerics


• Biotronik


• Boston Scientific Corporation


• R. Bard


• Cardinal Health


• Koninklijke Philips


• Minnetronix, Inc.


• Straub Medical

Recent Development

The shortage of healthcare professionals is more acute in rural regions, where the state owns most healthcare centers. Government schemes are funding heavily to improve health status in the rural areas.

August 2021

In August 2021, Medtronic applied to the United States Food and Drug Administration to approve TurboHawk plus Directional Atherectomy System, an updated version of its older and largely phased out atherectomy device. This device will facilitate increased atherectomy procedures during Peripheral arterial disease interventions.Intended Audience

• Medical device companies


• Biopharmaceutical companies


• Government institutions


• Research and Development (R&D) companies


• Medical research laboratories